Samsara BioCapital, LLC - ARCELLX INC ownership

ARCELLX INC's ticker is and the CUSIP is 03940C100. A total of 2 filers reported holding ARCELLX INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Samsara BioCapital, LLC ownership history of ARCELLX INC
ValueSharesWeighting
Q3 2023$22,027,485
+13.5%
613,9210.0%6.74%
+97.9%
Q2 2023$19,412,182
-30.7%
613,921
-32.5%
3.41%
-41.2%
Q1 2023$28,024,129
-5.5%
909,579
-5.0%
5.79%
-9.3%
Q4 2022$29,661,832
+48.5%
957,451
-10.0%
6.38%
+37.1%
Q3 2022$19,968,000
+3.8%
1,063,8350.0%4.66%
-9.2%
Q2 2022$19,234,000
+37.2%
1,063,835
+6.4%
5.13%
+45.3%
Q1 2022$14,016,000999,7273.53%
Other shareholders
ARCELLX INC shareholders Q4 2023
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 5,500,007$77,110,00039.48%
AJU IB Investment Co., Ltd. 1,380,890$19,360,00029.90%
Samsara BioCapital, LLC 999,727$14,016,0003.53%
Novo Holdings A/S 4,016,878$56,317,0002.97%
NEA Management Company, LLC 6,437,764$72,206,0002.09%
Soleus Capital Management, L.P. 989,739$13,876,0001.79%
CAXTON CORP 88,820$1,245,0001.55%
CLOUGH CAPITAL PARTNERS L P 1,209,876$16,619,0001.26%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,533,059$21,493,0000.66%
CAAS CAPITAL MANAGEMENT LP 404,495$5,671,0000.23%
View complete list of ARCELLX INC shareholders